🔎 Trials Near Me

Home › Interstitial Lung Diseases › Alabama › Birmingham

Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Birmingham, AL

9 pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Nagre-recruitPhase 3
  • University of Alabama at Birmingham, Birmingham
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07540988

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Nagre-recruitPhase 2
  • University of Alabama, Birmingham
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05798923

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Nagre-recruitPhase 2
  • UAB Lung Health Center, Birmingham
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Nagre-recruit
  • University of Alabama at Birmingham, Birmingham
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Nagre-recruitObservasyonal na pag-aaral
  • University of Alabama at Birmingham, Birmingham
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Nagre-recruitPhase 2
  • University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Nagre-recruitObservasyonal na pag-aaral
  • University of Alabama - Birmingham, Birmingham
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Nagre-recruitPhase 3
  • UAB Lung Health Center, Birmingham
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05943535

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Nagre-recruitPhase 2
  • University of Alabama at Birmingham, Birmingham
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT05975983

Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.